Managlay, Merry-an .

HRN: 07-90-25  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2025
MUPIROCIN 2%, 15G (TUBE)
09/29/2025
10/06/2025
SKIN
2%
BID
Lesions On Skin
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: